Biofrontera Inc. Earnings Per Share (Basic)
Biofrontera Inc. (BFRI) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- Biofrontera Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.05.
- Biofrontera Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.41.
- Biofrontera Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.62.
- Biofrontera Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.57.
- Biofrontera Inc. earnings per share, basic for fiscal 2025 was -$1.04.
- Biofrontera Inc. earnings per share, basic for fiscal 2024 was -$3.22.
- Biofrontera Inc. earnings per share, basic for fiscal 2023 was -$13.02.
- Biofrontera Inc. earnings per share, basic for fiscal 2022 was -$0.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-13 | -$0.44 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.41 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$1.04 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | -$0.62 10-Q · filed 2025-11-12 | -$1.67 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.57 10-Q · filed 2026-08-13 | -$1.05 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$0.47 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$3.22 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | -$0.98 10-Q · filed 2025-11-12 | -$3.39 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$0.05 10-Q · filed 2025-08-13 | -$2.45 10-Q · filed 2025-08-13 | ||||||
| 2024-03-31 | -$2.88 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$13.02 10-K · filed 2025-03-20 | |||||||
| 2023-09-30 | -$4.64 10-Q · filed 2024-11-14 | -$17.57 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$7.23 10-Q · filed 2024-08-14 | -$12.73 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$5.60 10-Q · filed 2024-05-15 | -$0.28 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | -$0.61 10-K · filed 2024-03-15 | -$0.03 10-K · filed 2023-03-13 | ||||||
| 2022-09-30 | -$2.26 10-Q · filed 2023-11-09 | -$0.11 10-Q · filed 2022-11-14 | $2.19 10-Q · filed 2023-11-09 | $0.11 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$0.90 10-Q · filed 2023-08-11 | -$0.05 10-Q · filed 2022-08-12 | $5.24 10-Q · filed 2023-08-11 | $0.26 10-Q · filed 2022-08-12 | ||||
| 2022-03-31 | $0.33 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | $0.65 derived: net income ÷ weighted average shares · filed 2023-10-03 | $4.29 derived: net income ÷ weighted average shares · filed 2023-10-03 | -$85.63 8-K · filed 2023-10-03 | -$4.28 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | -$2.00 10-Q · filed 2022-11-14 | -$2.90 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.46 10-Q · filed 2022-08-12 | -$0.90 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.44 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |